TRIUS THERAPEUTICS (TSRX) – Analyst Ratings
-
Aegis Capital Downgrades Trius Therapeutics (TSRX) to Hold
-
Guggenheim Downgrades Trius Therapeutics (TSRX) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to TSRX Stock Lookup